FDA Approves Medtronic AdaptiveStim Neurostimulator

The FDA approved Medtronic’s AdaptiveStim with the RestoreSensor neurostimulation system, according to a Medtronic news release.

Advertisement

The system uses motion sensor technology to automatically adapt stimulation levels to the needs of people with chronic back and leg pain. It also recognizes and remembers the correlation between a change in body position — as a person is standing, sitting or laying down — and stimulation level and will automatically adjust the level based on body position. It also records the frequency of posture changes.

Related Articles on Pain Management:
Researchers Find Success With Mind-Body Techniques for Reducing Pain
Sleep Problems Triple Women’s Fibromyalgia Risk
Pieces of the Puzzle: Creating a Multidisciplinary Approach to Pain Management

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.